InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Dorling Janet. Officer active across 1 company, notably CymaBay Therapeutics, Inc.. In total, 4 reports have been logged. Activity tracked since 10 November 2023. The latest transaction was filed on 12 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Dorling Janet is a declarant and a director of CymaBay Therapeutics, Inc. (XNAS). She has 4 filings in total, and across the sampled recent filings from 2023-11-14 to 2024-02-14, the most frequent transaction type is option exercise.